Filing Details
- Accession Number:
- 0001179110-17-012396
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-18 20:49:19
- Reporting Period:
- 2017-03-29
- Accepted Time:
- 2017-09-18 20:49:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1578845 | Allergan Plc | AGN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1268854 | L Brent Saunders | Clonshaugh Business And Technology Park, Coolock, Co. Dublin L2 D17 E400 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares, Par Value $0.001 | Acquisiton | 2017-03-29 | 43 | $242.21 | 131,135 | No | 4 | P | Direct | |
Ordinary Shares, Par Value $0.001 | Acquisiton | 2017-06-16 | 44 | $235.96 | 131,178 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Includes 42.52 shares acquired on March 29, 2017 pursuant to a broker-assisted dividend reinvestment plan.
- Includes 43.7680 shares acquired on June 16, 2017 pursuant to a broker-assisted dividend reinvestment plan.
- Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.